Trilochan Sahoo
Plus aucun poste en cours
Profil
Trilochan Sahoo worked as a Senior Director in the Clinical Cytogenetic Department at Quest Diagnostics Nichols Institute, Inc. He then worked as the VP of Clinical Affairs and Director of Cytogenetics at CombiMatrix Corp.
from 2014 to 2017.
Dr. Sahoo received his undergraduate degree from the University of Utkal and his doctorate from Christian Medical College.
Anciens postes connus de Trilochan Sahoo
| Sociétés | Poste | Fin |
|---|---|---|
| COMBIMATRIX CORP | Directeur Technique/Scientifique/R&D | 14/11/2017 |
Quest Diagnostics Nichols Institute, Inc.
 Quest Diagnostics Nichols Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Quest Diagnostics, Inc., Quest Diagnostics Nichols Institute, Inc. is a medical laboratory company. The company is based in Chantilly, VA. Quest Diagnostics Nichols Institute was acquired by Quest Diagnostics, Inc. from GTCR LLC on April 01, 2002 for $500 million. | Corporate Officer/Principal | - |
Formation de Trilochan Sahoo
| Christian Medical College | Doctorate Degree |
| University of Utkal | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
CombiMatrix Corp.
 CombiMatrix Corp. BiotechnologyHealth Technology CombiMatrix Corp. engages in the provision of clinical diagnostic services. It offers cytogenomic testing for preimplantation genetic testing, prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. The company was founded in October 1995 and is headquartered in Irvine, CA. | Health Technology |
Quest Diagnostics Nichols Institute, Inc.
Quest Diagnostics Nichols Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Quest Diagnostics, Inc., Quest Diagnostics Nichols Institute, Inc. is a medical laboratory company. The company is based in Chantilly, VA. Quest Diagnostics Nichols Institute was acquired by Quest Diagnostics, Inc. from GTCR LLC on April 01, 2002 for $500 million. | Commercial Services |